We are live on ! Find out more
ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

6 hedge funds and large institutions have $3.95M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.02% less ownership

Funds ownership: 3.29% → 3.28% (-0.02%)

14% less funds holding

Funds holding: 7 → 6 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

58% less capital inflows, than outflows

Capital inflows: $26.3K | Capital outflows: $62.2K

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FNY Investment Advisers
FNY Investment Advisers
New York
+$17.8K
2
Deutsche Bank
Deutsche Bank
Germany
+$5.51K
3
UBS Group
UBS Group
Switzerland
+$2.96K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$35K
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$26.2K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$1K

ASLN Hedge Fund Activity: Q3 2019 in Review

6 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q3 2019, worth a combined $3.95M — down 44% from $7.04M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ASLN and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was FNY Investment Advisers, adding an estimated $17.8K. The largest seller was Millennium Management, exiting entirely with an estimated $35K sold.

  • 6 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q3 2019, down from 7 in Q2 2019.
  • Funds reported $3.95M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q3 2019, down 44% quarter-over-quarter.
  • 1 fund opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q3 2019 and 2 closed out, a net change of -1 holder.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q3 2019 was FNY Investment Advisers, an estimated $17.8K added.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q3 2019 was Millennium Management, an estimated $35K sold.

Based on aggregated 13F filings for Q3 2019.